Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Corporate Healthcare Important Contracts.

Davis MW.

Dent Today. 2017 Jan;36(1):10, 12. No abstract available.

PMID:
29235769
2.

Juno-UVS approach observations of Jupiter's auroras.

Gladstone GR, Versteeg MH, Greathouse TK, Hue V, Davis MW, Gérard JC, Grodent DC, Bonfond B, Nichols JD, Wilson RJ, Hospodarsky GB, Bolton SJ, Levin SM, Connerney JEP, Adriani A, Kurth WS, Mauk BH, Valek P, McComas DJ, Orton GS, Bagenal F.

Geophys Res Lett. 2017 Aug 16;44(15):7668-7675. doi: 10.1002/2017GL073377. Epub 2017 Aug 4.

3.

Challenges Faced by Foreign National Dentists.

Davis MW.

Dent Today. 2016 Jul;35(7):10. No abstract available.

PMID:
28437044
4.

An Abundant Class of Non-coding DNA Can Prevent Stochastic Gene Silencing in the C. elegans Germline.

Frøkjær-Jensen C, Jain N, Hansen L, Davis MW, Li Y, Zhao D, Rebora K, Millet JRM, Liu X, Kim SK, Dupuy D, Jorgensen EM, Fire AZ.

Cell. 2016 Jul 14;166(2):343-357. doi: 10.1016/j.cell.2016.05.072. Epub 2016 Jun 30.

5.

Highly efficient baculovirus-mediated multigene delivery in primary cells.

Mansouri M, Bellon-Echeverria I, Rizk A, Ehsaei Z, Cianciolo Cosentino C, Silva CS, Xie Y, Boyce FM, Davis MW, Neuhauss SC, Taylor V, Ballmer-Hofer K, Berger I, Berger P.

Nat Commun. 2016 May 4;7:11529. doi: 10.1038/ncomms11529.

6.

Effective modulus of the human intervertebral disc and its effect on vertebral bone stress.

Yang H, Jekir MG, Davis MW, Keaveny TM.

J Biomech. 2016 May 3;49(7):1134-1140. doi: 10.1016/j.jbiomech.2016.02.045. Epub 2016 Feb 27.

7.

Clathrin regenerates synaptic vesicles from endosomes.

Watanabe S, Trimbuch T, Camacho-Pérez M, Rost BR, Brokowski B, Söhl-Kielczynski B, Felies A, Davis MW, Rosenmund C, Jorgensen EM.

Nature. 2014 Nov 13;515(7526):228-33. doi: 10.1038/nature13846. Epub 2014 Oct 8.

8.

Random and targeted transgene insertion in Caenorhabditis elegans using a modified Mos1 transposon.

Frøkjær-Jensen C, Davis MW, Sarov M, Taylor J, Flibotte S, LaBella M, Pozniakovsky A, Moerman DG, Jorgensen EM.

Nat Methods. 2014 May;11(5):529-34. doi: 10.1038/nmeth.2889. Epub 2014 Mar 16.

9.

Effect of steady-state atorvastatin on the pharmacokinetics of a single dose of colchicine in healthy adults under fasted conditions.

Davis MW, Wason S.

Clin Drug Investig. 2014 Apr;34(4):259-67. doi: 10.1007/s40261-013-0168-8.

PMID:
24452746
10.

Ultrafast endocytosis at mouse hippocampal synapses.

Watanabe S, Rost BR, Camacho-Pérez M, Davis MW, Söhl-Kielczynski B, Rosenmund C, Jorgensen EM.

Nature. 2013 Dec 12;504(7479):242-247. doi: 10.1038/nature12809. Epub 2013 Dec 4.

11.

Ultrafast endocytosis at Caenorhabditis elegans neuromuscular junctions.

Watanabe S, Liu Q, Davis MW, Hollopeter G, Thomas N, Jorgensen NB, Jorgensen EM.

Elife. 2013 Sep 3;2:e00723. doi: 10.7554/eLife.00723.

12.

Colchicine-antimicrobial drug interactions: what pharmacists need to know in treating gout.

Davis MW, Wason S, Digiacinto JL.

Consult Pharm. 2013 Mar;28(3):176-83. doi: 10.4140/TCP.n.2013.176. Review.

PMID:
23462027
13.

Pharmacokinetics of colchicine in pediatric and adult patients with familial Mediterranean fever.

Berkun Y, Wason S, Brik R, Butbul Y, Ben-Chetrit E, Hashkes PJ, Livneh A, Ozen S, Ozdogan H, Faulkner R, Davis MW.

Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):1121-30.

PMID:
23298502
14.

Effects of grapefruit and Seville orange juices on the pharmacokinetic properties of colchicine in healthy subjects.

Wason S, DiGiacinto JL, Davis MW.

Clin Ther. 2012 Oct;34(10):2161-73. doi: 10.1016/j.clinthera.2012.08.007. Epub 2012 Aug 31.

15.

Effect of cyclosporine on the pharmacokinetics of colchicine in healthy subjects.

Wason S, Digiacinto JL, Davis MW.

Postgrad Med. 2012 Jul;124(4):189-96. doi: 10.3810/pgm.2012.07.2579.

PMID:
22913907
16.

Are dosing adjustments required for colchicine in the elderly compared with younger patients?

Wason S, Faulkner RD, Davis MW.

Adv Ther. 2012 Jun;29(6):551-61. doi: 10.1007/s12325-012-0028-6. Epub 2012 Jun 29.

PMID:
22753019
17.

Clinical profiles and risk factors for outcomes in older patients with cervical and trochanteric hip fracture: similarities and differences.

Fisher AA, Srikusalanukul W, Davis MW, Smith PN.

J Trauma Manag Outcomes. 2012 Feb 15;6(1):2. doi: 10.1186/1752-2897-6-2.

18.

Improved Mos1-mediated transgenesis in C. elegans.

Frøkjær-Jensen C, Davis MW, Ailion M, Jorgensen EM.

Nat Methods. 2012 Jan 30;9(2):117-8. doi: 10.1038/nmeth.1865. No abstract available.

19.

Unapproved drugs in the United States and the Food and Drug Administration.

Nasr A, Lauterio TJ, Davis MW.

Adv Ther. 2011 Oct;28(10):842-56. doi: 10.1007/s12325-011-0059-4. Epub 2011 Sep 1. Review.

PMID:
21894470
20.

To the full.

Davis MW.

Can Fam Physician. 2011 Jul;57(7):761. No abstract available.

22.

UNC119 is required for G protein trafficking in sensory neurons.

Zhang H, Constantine R, Vorobiev S, Chen Y, Seetharaman J, Huang YJ, Xiao R, Montelione GT, Gerstner CD, Davis MW, Inana G, Whitby FG, Jorgensen EM, Hill CP, Tong L, Baehr W.

Nat Neurosci. 2011 Jun 5;14(7):874-80. doi: 10.1038/nn.2835.

23.

Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors.

Terkeltaub RA, Furst DE, Digiacinto JL, Kook KA, Davis MW.

Arthritis Rheum. 2011 Aug;63(8):2226-37. doi: 10.1002/art.30389. Erratum in: Arthritis Rheum. 2011 Nov;63(11):3521. Dosage error in article text.

24.

A new perspective on the pharmacoeconomics of colchicine.

Wertheimer AI, Davis MW, Lauterio TJ.

Curr Med Res Opin. 2011 May;27(5):931-7. doi: 10.1185/03007995.2011.563284. Epub 2011 Mar 3. Review.

PMID:
21370937
25.

Protein localization in electron micrographs using fluorescence nanoscopy.

Watanabe S, Punge A, Hollopeter G, Willig KI, Hobson RJ, Davis MW, Hell SW, Jorgensen EM.

Nat Methods. 2011 Jan;8(1):80-4. doi: 10.1038/nmeth.1537. Epub 2010 Nov 21.

26.

LRO-LAMP observations of the LCROSS impact plume.

Gladstone GR, Hurley DM, Retherford KD, Feldman PD, Pryor WR, Chaufray JY, Versteeg M, Greathouse TK, Steffl AJ, Throop H, Parker JW, Kaufmann DE, Egan AF, Davis MW, Slater DC, Mukherjee J, Miles PF, Hendrix AR, Colaprete A, Stern SA.

Science. 2010 Oct 22;330(6003):472-6. doi: 10.1126/science.1186474. Erratum in: Science. 2011 Sep 23;333(6050):1703.

27.

The seven stages of EMR adoption. Majority of hospitals are in stage 3 and rising.

Davis MW.

Healthc Exec. 2010 May-Jun;25(3):18-9. No abstract available.

PMID:
20486594
28.

Targeted gene deletions in C. elegans using transposon excision.

Frøkjaer-Jensen C, Davis MW, Hollopeter G, Taylor J, Harris TW, Nix P, Lofgren R, Prestgard-Duke M, Bastiani M, Moerman DG, Jorgensen EM.

Nat Methods. 2010 Jun;7(6):451-3. doi: 10.1038/nmeth.1454. Epub 2010 Apr 25.

29.
30.

Understanding the code.

Davis MW.

J Am Dent Assoc. 2009 Nov;140(11):1344-7; author reply 1347. No abstract available.

PMID:
19884387
31.

Serum leptin levels in older patients with hip fracture--impact on peri-operative myocardial injury.

Fisher AA, Goh SL, Srikusalankul W, Southcott EN, Davis MW.

Am Heart Hosp J. 2009 Summer;7(1):9-16.

PMID:
19742442
32.

Trends in hip fracture epidemiology in Australia: possible impact of bisphosphonates and hormone replacement therapy.

Fisher AA, O'Brien ED, Davis MW.

Bone. 2009 Aug;45(2):246-53. doi: 10.1016/j.bone.2009.04.244. Epub 2009 May 3.

PMID:
19409518
33.

Single-copy insertion of transgenes in Caenorhabditis elegans.

Frøkjaer-Jensen C, Davis MW, Hopkins CE, Newman BJ, Thummel JM, Olesen SP, Grunnet M, Jorgensen EM.

Nat Genet. 2008 Nov;40(11):1375-83. doi: 10.1038/ng.248. Epub 2008 Oct 26.

34.

The effect of tricaine on use of the fluorescein test for detecting skin and corneal ulcers in fish.

Davis MW, Stephenson J, Noga EJ.

J Aquat Anim Health. 2008 Jun;20(2):86-95. doi: 10.1577/H07-023.1.

PMID:
18783129
35.

Gene conversion and end-joining-repair double-strand breaks in the Caenorhabditis elegans germline.

Robert VJ, Davis MW, Jorgensen EM, Bessereau JL.

Genetics. 2008 Sep;180(1):673-9. doi: 10.1534/genetics.108.089698. Epub 2008 Aug 30.

36.

Comparative study of xylanase kinetics using dinitrosalicylic, arsenomolybdate, and ion chromatographic assays.

Jeffries TW, Yang VW, Davis MW.

Appl Biochem Biotechnol. 1998 Spring;70-72:257-65. doi: 10.1007/BF02920142.

PMID:
18575995
37.

Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.

Kimball AB, Gold MH, Zib B, Davis MW; Clobetasol Propionate Emulsion Formulation Foam Phase III Clinical Study Group.

J Am Acad Dermatol. 2008 Sep;59(3):448-54, 454.e1. doi: 10.1016/j.jaad.2008.04.020. Epub 2008 Jun 9.

PMID:
18539358
38.

Gene activation using FLP recombinase in C. elegans.

Davis MW, Morton JJ, Carroll D, Jorgensen EM.

PLoS Genet. 2008 Mar 21;4(3):e1000028. doi: 10.1371/journal.pgen.1000028.

39.

Elevated serum cardiac troponin I in older patients with hip fracture: incidence and prognostic significance.

Fisher AA, Southcott EN, Goh SL, Srikusalanukul W, Hickman PE, Davis MW, Potter JM, Budge MM, Smith PN.

Arch Orthop Trauma Surg. 2008 Oct;128(10):1073-9. doi: 10.1007/s00402-007-0554-x. Epub 2008 Jan 12.

PMID:
18193436
40.

Protons act as a transmitter for muscle contraction in C. elegans.

Beg AA, Ernstrom GG, Nix P, Davis MW, Jorgensen EM.

Cell. 2008 Jan 11;132(1):149-60. doi: 10.1016/j.cell.2007.10.058.

41.

Prolonged QT interval, syncope, and delirium with galantamine.

Fisher AA, Davis MW.

Ann Pharmacother. 2008 Feb;42(2):278-83. doi: 10.1345/aph.1K514. Epub 2008 Jan 8.

PMID:
18182475
42.

Altered blood pressure homeostasis in the oldest old and survival.

Fisher AA, Davis MW.

J Am Geriatr Soc. 2007 Dec;55(12):2102-3. No abstract available.

PMID:
18081688
43.

Io's atmospheric response to eclipse: UV aurorae observations.

Retherford KD, Spencer JR, Stern SA, Saur J, Strobel DF, Steffl AJ, Gladstone GR, Weaver HA, Cheng AF, Parker JW, Slater DC, Versteeg MH, Davis MW, Bagenal F, Throop HB, Lopes RM, Reuter DC, Lunsford A, Conard SJ, Young LA, Moore JM.

Science. 2007 Oct 12;318(5848):237-40.

44.

Jupiter's nightside airglow and aurora.

Gladstone GR, Stern SA, Slater DC, Versteeg M, Davis MW, Retherford KD, Young LA, Steffl AJ, Throop H, Parker JW, Weaver HA, Cheng AF, Orton GS, Clarke JT, Nichols JD.

Science. 2007 Oct 12;318(5848):229-31.

45.

Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures.

Fisher AA, Southcott EK, Srikusalanukul W, Davis MW, Hickman PE, Potter JM, Smith PN.

Ann Clin Lab Sci. 2007 Summer;37(3):222-32.

PMID:
17709685
46.

Is the current anti-osteoporotic therapy paradigm good enough?

Fisher AA, Davis MW.

J Am Geriatr Soc. 2006 Dec;54(12):1960-1, author reply 1961-3. No abstract available.

PMID:
17198519
47.

Calcium-PTH-vitamin D axis in older patients with hip fracture.

Fisher AA, Davis MW.

Osteoporos Int. 2007 May;18(5):693-5; author reply 697. Epub 2006 Nov 23. No abstract available.

PMID:
17122955
48.

Induction and repair of zinc-finger nuclease-targeted double-strand breaks in Caenorhabditis elegans somatic cells.

Morton J, Davis MW, Jorgensen EM, Carroll D.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16370-5. Epub 2006 Oct 23.

49.

Single-nucleotide polymorphism mapping.

Davis MW, Hammarlund M.

Methods Mol Biol. 2006;351:75-92. Review.

PMID:
16988427
50.

Cytokines, infections, stress, and dysphoric moods in breastfeeders and formula feeders.

Groer MW, Davis MW.

J Obstet Gynecol Neonatal Nurs. 2006 Sep-Oct;35(5):599-607.

PMID:
16958715

Supplemental Content

Loading ...
Support Center